ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+106.1%
5Y CAGR+34.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+106.1%/yr
vs -13.7%/yr prior
5Y CAGR
+34.1%/yr
Recent acceleration
Acceleration
+119.8pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
4.3x
Strong expansion
Streak
3 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $89.00M | +8.7% |
| 2024 | $81.84M | +79.0% |
| 2023 | $45.73M | +349.8% |
| 2022 | $10.17M | -46.9% |
| 2021 | $19.14M | -6.9% |
| 2020 | $20.55M | +4.9% |
| 2019 | $19.60M | +6.9% |
| 2018 | $18.33M | +40.4% |
| 2017 | $13.06M | +196.4% |
| 2016 | $4.41M | - |